A Randomized, Double-masked, Multicenter,Sham-controlled, Safety and Efficacy Study of KH902 in Patients With Wet AMD

Name: A Randomized, Double-masked, Multicenter,Sham-controlled, Safety and Efficacy Study of KH902 in Patients With Wet AMD
Published: 2011
License: Public Domain

Chengdu Kanghong Biotech Co., Ltd. · 2011

ClinicalTrials.gov · Datasets · License: Public Domain · 2011

Open Source ↗

neovascular age-related macular degeneration, recombinant human vegf receptor-fc fusion protein (kh902), age-related macular degeneration (amd), choroidal neovascularization (cnv), intravitreal injection, best corrected visual acuity (bcva), central retinal thickness, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Randomized, Double-masked, Multicenter,Sham-controlled, Safety and Efficacy Study of KH902 in Patients With Wet AMD

Related documents